0001104659-23-128727.txt : 20231222 0001104659-23-128727.hdr.sgml : 20231222 20231222142119 ACCESSION NUMBER: 0001104659-23-128727 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231222 DATE AS OF CHANGE: 20231222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEALY JAMES CENTRAL INDEX KEY: 0001245624 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 231509288 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 tm2333601-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-12-13 0 0001604821 Natera, Inc. NTRA 0001245624 HEALY JAMES C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 1 0 0 0 0 Common Stock 2023-12-13 4 S 0 644000 58.75 D 0 I by Sofinnova Management VIII, L.L.C. Common Stock 1550280 I by Sofinnova Venture Partners IX, L.P. Common Stock 42236 D Includes 644,000 shares of Common Stock of the Issuer received by Sofinnova Management VIII, L.L.C. ("SM VIII") from a pro-rata in-kind distribution of Common Stock of the Issuer by Sofinnova Venture Partners VIII, L.P. ("SVP VIII") without consideration to the partners of SVP VIII in accordance with the limited partnership agreement of SVP VIII. In prior reports, the Reporting Person reported beneficial ownership of 1,550,280 shares of Common Stock of the Issuer held by SVP VIII. The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.75 to $59.695, inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission,upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. All shares held by SM VIII. Mr. Healy is the managing member of SM VIII. SM VIII is the general partner of SVP VIII. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. All shares held by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Mr. Healy is the managing member of Sofinnova Management IX, L.L.C. ("SM IX"). SM IX is the general partner of SVP IX. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. /s/ Nathalie Auber, Attorney-in-Fact 2023-12-21